<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>7267942</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31868305</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">7267942</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1002/hbm.24906</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">HBM24906</article-id></all-ids><extracted-table><table-id>hbm24906-tbl-0001</table-id><table-label>Table 1</table-label><table-caption>The characteristics of subjects in Experiments 1 and 2</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="hbm24906-tbl-0001" xml:lang="en" orientation="portrait" position="float"><label>Table 1</label><caption><p>The characteristics of subjects in Experiments 1 and 2</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><col align="left" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Experiment 1</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">Experiment 2</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Variables</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1">Categories</th><th align="left" valign="bottom" rowspan="1" colspan="1">SCZ (<italic>n</italic> = 21)</th><th align="left" valign="bottom" rowspan="1" colspan="1">HC (<italic>n</italic> = 21)</th><th align="left" valign="bottom" rowspan="1" colspan="1">SCZ (n = 20)</th><th align="left" valign="bottom" rowspan="1" colspan="1">HC (n = 20)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Age, y</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">37.6 ± 7.9</td><td align="left" valign="top" rowspan="1" colspan="1">34.4 ± 7.2</td><td align="left" valign="top" rowspan="1" colspan="1">37.9 ± 7.1</td><td align="left" valign="top" rowspan="1" colspan="1">34.4 ± 6.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Education, y</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">13.7 ± 2.5</td><td align="left" valign="top" rowspan="1" colspan="1">14.6 ± 3.5</td><td align="left" valign="top" rowspan="1" colspan="1">14.0 ± 2.6</td><td align="left" valign="top" rowspan="1" colspan="1">14.3 ± 3.6</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Gender, no. (%)</td><td align="left" valign="top" rowspan="1" colspan="1">Male</td><td align="left" valign="top" rowspan="1" colspan="1">16 (76.2%)</td><td align="left" valign="top" rowspan="1" colspan="1">16 (76.2%)</td><td align="left" valign="top" rowspan="1" colspan="1">15 (75.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">16 (80.0%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Female</td><td align="left" valign="top" rowspan="1" colspan="1">5 (23.8%)</td><td align="left" valign="top" rowspan="1" colspan="1">5 (23.8%)</td><td align="left" valign="top" rowspan="1" colspan="1">5 (25.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">4 (20.0%)</td></tr><tr><td rowspan="2" align="left" valign="top" colspan="1">Ethnicity, no. (%)</td><td align="left" valign="top" rowspan="1" colspan="1">Han</td><td align="left" valign="top" rowspan="1" colspan="1">18 (85.7%)</td><td align="left" valign="top" rowspan="1" colspan="1">21 (100%)</td><td align="left" valign="top" rowspan="1" colspan="1">18 (90.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">20 (100%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Minority</td><td align="left" valign="top" rowspan="1" colspan="1">3 (14.3%)</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="left" valign="top" rowspan="1" colspan="1">2 (10.0%)</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Onset‐age of SCZ, y</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">22.0 ± 6.8</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">21.9 ± 6.9</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duration of SCZ, y</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">15.9 ± 8.0</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">16.6 ± 7.8</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Positive symptoms</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">13.2 ± 5.2</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">13.3 ± 5.1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Negative symptoms</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">16.4 ± 7.5</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">16.1 ± 7.6</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">General psychosis</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">25.7 ± 5.9</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">24.9 ± 5.2</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PANSS</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">55.3 ± 12.9</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">54.3 ± 13.1</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Personal/family history of psychosis, no. (%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0%)</td><td align="left" valign="top" rowspan="1" colspan="1">0 (0%)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Duration of smoke, y</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">11.1 ± 6.7 (<italic>n</italic> = 9)</td><td align="left" valign="top" rowspan="1" colspan="1">14.4 ± 9.9 (<italic>n</italic> = 7)</td><td align="left" valign="top" rowspan="1" colspan="1">9.3 ± 5.4 (<italic>n</italic> = 10)</td><td align="left" valign="top" rowspan="1" colspan="1">14.4 ± 9.9 (<italic>n</italic> = 7)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Daily dose of smoke, no.</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">8.7 ± 7.6</td><td align="left" valign="top" rowspan="1" colspan="1">10.0 ± 9.5</td><td align="left" valign="top" rowspan="1" colspan="1">8.3 ± 7.3</td><td align="left" valign="top" rowspan="1" colspan="1">10.0 ± 9.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Antipsychotic dosage,<xref ref-type="fn" rid="hbm24906-note-0002">a</xref> mg</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">608.5 ± 262.9</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">659.5 ± 269.7</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">First‐generation antipsychotic,<xref ref-type="fn" rid="hbm24906-note-0003">b</xref> no. (%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2 (9.5%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">2 (10.0%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Second‐generation antipsychotic,<xref ref-type="fn" rid="hbm24906-note-0003">b</xref> no. (%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">19(90.5%)</td><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1">18(90.0%)</td><td align="left" valign="top" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot id="hbm24906-ntgp-0001"><fn id="hbm24906-note-0001"><p><italic>Note</italic>: Data are expressed in mean ± SD.</p></fn><fn id="hbm24906-note-0002"><label>a</label><p>Antipsychotic dosage has been converted into chlorpromazine equivalents.</p></fn><fn id="hbm24906-note-0003"><label>b</label><p>Some patients were taking both first‐generation and second‐generation antipsychotics.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">The characteristics of subjects in Experiments 1 and 2</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><col align="left"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom"/><th align="left" style="border-bottom:solid 1px #000000" valign="bottom"/><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom">Experiment 1</th><th colspan="2" align="left" style="border-bottom:solid 1px #000000" valign="bottom">Experiment 2</th></tr><tr style="border-bottom:solid 1px #000000"><th align="left" style="border-bottom:solid 1px #000000" valign="bottom">Variables</th><th align="left" style="border-bottom:solid 1px #000000" valign="bottom">Categories</th><th align="left" valign="bottom">SCZ (n = 21)</th><th align="left" valign="bottom">HC (n = 21)</th><th align="left" valign="bottom">SCZ (n = 20)</th><th align="left" valign="bottom">HC (n = 20)</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top">Age, y</td><td align="left" valign="top"/><td align="left" valign="top">37.6 ± 7.9</td><td align="left" valign="top">34.4 ± 7.2</td><td align="left" valign="top">37.9 ± 7.1</td><td align="left" valign="top">34.4 ± 6.5</td></tr><tr><td align="left" valign="top">Education, y</td><td align="left" valign="top"/><td align="left" valign="top">13.7 ± 2.5</td><td align="left" valign="top">14.6 ± 3.5</td><td align="left" valign="top">14.0 ± 2.6</td><td align="left" valign="top">14.3 ± 3.6</td></tr><tr><td rowspan="2" align="left" valign="top">Gender, no. (%)</td><td align="left" valign="top">Male</td><td align="left" valign="top">16 (76.2%)</td><td align="left" valign="top">16 (76.2%)</td><td align="left" valign="top">15 (75.0%)</td><td align="left" valign="top">16 (80.0%)</td></tr><tr><td align="left" valign="top">Female</td><td align="left" valign="top">5 (23.8%)</td><td align="left" valign="top">5 (23.8%)</td><td align="left" valign="top">5 (25.0%)</td><td align="left" valign="top">4 (20.0%)</td></tr><tr><td rowspan="2" align="left" valign="top">Ethnicity, no. (%)</td><td align="left" valign="top">Han</td><td align="left" valign="top">18 (85.7%)</td><td align="left" valign="top">21 (100%)</td><td align="left" valign="top">18 (90.0%)</td><td align="left" valign="top">20 (100%)</td></tr><tr><td align="left" valign="top">Minority</td><td align="left" valign="top">3 (14.3%)</td><td align="left" valign="top">0 (0%)</td><td align="left" valign="top">2 (10.0%)</td><td align="left" valign="top">0 (0%)</td></tr><tr><td align="left" valign="top">Onset‐age of SCZ, y</td><td align="left" valign="top"/><td align="left" valign="top">22.0 ± 6.8</td><td align="left" valign="top"/><td align="left" valign="top">21.9 ± 6.9</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Duration of SCZ, y</td><td align="left" valign="top"/><td align="left" valign="top">15.9 ± 8.0</td><td align="left" valign="top"/><td align="left" valign="top">16.6 ± 7.8</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Positive symptoms</td><td align="left" valign="top"/><td align="left" valign="top">13.2 ± 5.2</td><td align="left" valign="top"/><td align="left" valign="top">13.3 ± 5.1</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Negative symptoms</td><td align="left" valign="top"/><td align="left" valign="top">16.4 ± 7.5</td><td align="left" valign="top"/><td align="left" valign="top">16.1 ± 7.6</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">General psychosis</td><td align="left" valign="top"/><td align="left" valign="top">25.7 ± 5.9</td><td align="left" valign="top"/><td align="left" valign="top">24.9 ± 5.2</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">PANSS</td><td align="left" valign="top"/><td align="left" valign="top">55.3 ± 12.9</td><td align="left" valign="top"/><td align="left" valign="top">54.3 ± 13.1</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Personal/family history of psychosis, no. (%)</td><td align="left" valign="top"/><td align="left" valign="top">0 (0%)</td><td align="left" valign="top">0 (0%)</td><td align="left" valign="top">0 (0%)</td><td align="left" valign="top">0 (0%)</td></tr><tr><td align="left" valign="top">Duration of smoke, y</td><td align="left" valign="top"/><td align="left" valign="top">11.1 ± 6.7 (n = 9)</td><td align="left" valign="top">14.4 ± 9.9 (n = 7)</td><td align="left" valign="top">9.3 ± 5.4 (n = 10)</td><td align="left" valign="top">14.4 ± 9.9 (n = 7)</td></tr><tr><td align="left" valign="top">Daily dose of smoke, no.</td><td align="left" valign="top"/><td align="left" valign="top">8.7 ± 7.6</td><td align="left" valign="top">10.0 ± 9.5</td><td align="left" valign="top">8.3 ± 7.3</td><td align="left" valign="top">10.0 ± 9.5</td></tr><tr><td align="left" valign="top">Antipsychotic dosage,??? mg</td><td align="left" valign="top"/><td align="left" valign="top">608.5 ± 262.9</td><td align="left" valign="top"/><td align="left" valign="top">659.5 ± 269.7</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">First‐generation antipsychotic,??? no. (%)</td><td align="left" valign="top"/><td align="left" valign="top">2 (9.5%)</td><td align="left" valign="top"/><td align="left" valign="top">2 (10.0%)</td><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Second‐generation antipsychotic,??? no. (%)</td><td align="left" valign="top"/><td align="left" valign="top">19(90.5%)</td><td align="left" valign="top"/><td align="left" valign="top">18(90.0%)</td><td align="left" valign="top"/></tr></tbody></table></div>Note: Data are expressed in mean ± SD.aAntipsychotic dosage has been converted into chlorpromazine equivalents.bSome patients were taking both first‐generation and second‐generation antipsychotics.</transformed-table></extracted-table><extracted-table><table-id>hbm24906-tbl-0002</table-id><table-label>Table 2</table-label><table-caption>Comparisons of psychophysics and electrophysiological features between SCZ and HC</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="hbm24906-tbl-0002" xml:lang="en" orientation="portrait" position="float"><label>Table 2</label><caption><p>Comparisons of psychophysics and electrophysiological features between SCZ and HC</p></caption><table frame="hsides" rules="groups"><col align="left" span="1"/><col align="left" span="1"/><col align="char" char="." span="1"/><col align="char" char="." span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom" rowspan="1" colspan="1">Features</th><th align="left" valign="bottom" rowspan="1" colspan="1">Variables</th><th align="left" valign="bottom" rowspan="1" colspan="1">SCZ (<italic>n</italic> = 21)</th><th align="left" valign="bottom" rowspan="1" colspan="1">HC (<italic>n</italic> = 21)</th></tr></thead><tbody valign="top"><tr><td rowspan="3" align="left" valign="top" colspan="1">Perceived intensities</td><td align="left" valign="top" rowspan="1" colspan="1">Nociceptive</td><td align="char" valign="top" rowspan="1" colspan="1">3.7 ± 1.4</td><td align="char" valign="top" rowspan="1" colspan="1">5.4 ± 1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Non‐nociceptive somatosensory</td><td align="char" valign="top" rowspan="1" colspan="1">4.4 ± 1.4</td><td align="char" valign="top" rowspan="1" colspan="1">5.1 ± 1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Auditory</td><td align="char" valign="top" rowspan="1" colspan="1">4.2 ± 1.6</td><td align="char" valign="top" rowspan="1" colspan="1">4.8 ± 1.6</td></tr><tr><td rowspan="6" align="left" valign="top" colspan="1">LEP responses</td><td align="left" valign="top" rowspan="1" colspan="1">N1 latency (ms)</td><td align="char" valign="top" rowspan="1" colspan="1">206.0 ± 27.9</td><td align="char" valign="top" rowspan="1" colspan="1">174.6 ± 27.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N1 amplitude (μV)</td><td align="char" valign="top" rowspan="1" colspan="1">−1.4 ± 1.1</td><td align="char" valign="top" rowspan="1" colspan="1">−6.6 ± 5.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N2 latency (ms)</td><td align="char" valign="top" rowspan="1" colspan="1">254.1 ± 41.0</td><td align="char" valign="top" rowspan="1" colspan="1">217.1 ± 31.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N2 amplitude (μV)</td><td align="char" valign="top" rowspan="1" colspan="1">−4.5 ± 2.4</td><td align="char" valign="top" rowspan="1" colspan="1">−16.1 ± 12.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P2 latency (ms)</td><td align="char" valign="top" rowspan="1" colspan="1">397.3 ± 41.3</td><td align="char" valign="top" rowspan="1" colspan="1">356.0 ± 49.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P2 amplitude (μV)</td><td align="char" valign="top" rowspan="1" colspan="1">4.3 ± 4.3</td><td align="char" valign="top" rowspan="1" colspan="1">15.9 ± 13.4</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">SEP responses</td><td align="left" valign="top" rowspan="1" colspan="1">N2 latency (ms)</td><td align="char" valign="top" rowspan="1" colspan="1">127.4 ± 40.6</td><td align="char" valign="top" rowspan="1" colspan="1">119.9 ± 9.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N2 amplitude (μV)</td><td align="char" valign="top" rowspan="1" colspan="1">−9.2 ± 6.9</td><td align="char" valign="top" rowspan="1" colspan="1">−19.9 ± 10.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P2 latency (ms)</td><td align="char" valign="top" rowspan="1" colspan="1">260.3 ± 32.9</td><td align="char" valign="top" rowspan="1" colspan="1">256.0 ± 41.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P2 amplitude (μV)</td><td align="char" valign="top" rowspan="1" colspan="1">23.4 ± 8.6</td><td align="char" valign="top" rowspan="1" colspan="1">28.3 ± 14.6</td></tr><tr><td rowspan="4" align="left" valign="top" colspan="1">AEP responses</td><td align="left" valign="top" rowspan="1" colspan="1">N2 latency (ms)</td><td align="char" valign="top" rowspan="1" colspan="1">141.3 ± 9.9</td><td align="char" valign="top" rowspan="1" colspan="1">142.4 ± 12.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">N2 amplitude (μV)</td><td align="char" valign="top" rowspan="1" colspan="1">−14.8 ± 8.4</td><td align="char" valign="top" rowspan="1" colspan="1">−23.5 ± 7.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P2 latency (ms)</td><td align="char" valign="top" rowspan="1" colspan="1">260.9 ± 43.8</td><td align="char" valign="top" rowspan="1" colspan="1">240.0 ± 29.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P2 amplitude (μV)</td><td align="char" valign="top" rowspan="1" colspan="1">18.7 ± 7.9</td><td align="char" valign="top" rowspan="1" colspan="1">17.6 ± 6.9</td></tr></tbody></table><table-wrap-foot id="hbm24906-ntgp-0002"><fn id="hbm24906-note-0004"><p><italic>Note</italic>: Data are expressed in mean ± SD.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Comparisons of psychophysics and electrophysiological features between SCZ and HC</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000"><th align="left" valign="bottom">Features</th><th align="left" valign="bottom">Variables</th><th align="left" valign="bottom">SCZ (n = 21)</th><th align="left" valign="bottom">HC (n = 21)</th></tr></thead><tbody valign="top"><tr><td rowspan="3" align="left" valign="top">Perceived intensities</td><td align="left" valign="top">Nociceptive</td><td align="char" valign="top">3.7 ± 1.4</td><td align="char" valign="top">5.4 ± 1.5</td></tr><tr><td align="left" valign="top">Non‐nociceptive somatosensory</td><td align="char" valign="top">4.4 ± 1.4</td><td align="char" valign="top">5.1 ± 1.6</td></tr><tr><td align="left" valign="top">Auditory</td><td align="char" valign="top">4.2 ± 1.6</td><td align="char" valign="top">4.8 ± 1.6</td></tr><tr><td rowspan="6" align="left" valign="top">LEP responses</td><td align="left" valign="top">N1 latency (ms)</td><td align="char" valign="top">206.0 ± 27.9</td><td align="char" valign="top">174.6 ± 27.7</td></tr><tr><td align="left" valign="top">N1 amplitude (μV)</td><td align="char" valign="top">−1.4 ± 1.1</td><td align="char" valign="top">−6.6 ± 5.9</td></tr><tr><td align="left" valign="top">N2 latency (ms)</td><td align="char" valign="top">254.1 ± 41.0</td><td align="char" valign="top">217.1 ± 31.5</td></tr><tr><td align="left" valign="top">N2 amplitude (μV)</td><td align="char" valign="top">−4.5 ± 2.4</td><td align="char" valign="top">−16.1 ± 12.5</td></tr><tr><td align="left" valign="top">P2 latency (ms)</td><td align="char" valign="top">397.3 ± 41.3</td><td align="char" valign="top">356.0 ± 49.7</td></tr><tr><td align="left" valign="top">P2 amplitude (μV)</td><td align="char" valign="top">4.3 ± 4.3</td><td align="char" valign="top">15.9 ± 13.4</td></tr><tr><td rowspan="4" align="left" valign="top">SEP responses</td><td align="left" valign="top">N2 latency (ms)</td><td align="char" valign="top">127.4 ± 40.6</td><td align="char" valign="top">119.9 ± 9.6</td></tr><tr><td align="left" valign="top">N2 amplitude (μV)</td><td align="char" valign="top">−9.2 ± 6.9</td><td align="char" valign="top">−19.9 ± 10.3</td></tr><tr><td align="left" valign="top">P2 latency (ms)</td><td align="char" valign="top">260.3 ± 32.9</td><td align="char" valign="top">256.0 ± 41.7</td></tr><tr><td align="left" valign="top">P2 amplitude (μV)</td><td align="char" valign="top">23.4 ± 8.6</td><td align="char" valign="top">28.3 ± 14.6</td></tr><tr><td rowspan="4" align="left" valign="top">AEP responses</td><td align="left" valign="top">N2 latency (ms)</td><td align="char" valign="top">141.3 ± 9.9</td><td align="char" valign="top">142.4 ± 12.5</td></tr><tr><td align="left" valign="top">N2 amplitude (μV)</td><td align="char" valign="top">−14.8 ± 8.4</td><td align="char" valign="top">−23.5 ± 7.6</td></tr><tr><td align="left" valign="top">P2 latency (ms)</td><td align="char" valign="top">260.9 ± 43.8</td><td align="char" valign="top">240.0 ± 29.3</td></tr><tr><td align="left" valign="top">P2 amplitude (μV)</td><td align="char" valign="top">18.7 ± 7.9</td><td align="char" valign="top">17.6 ± 6.9</td></tr></tbody></table></div>Note: Data are expressed in mean ± SD.</transformed-table></extracted-table></extracted-tables-set>